Biocorp (PAR:ALCOR) said today that it inked a deal for its NewGuard safety syringe technology with “a leading global player specializing in pharmaceutical products” that it’s not allowed to name.
The Issoire, France-based company said the deal call for it to integrate and commercialize the NewGuard technology into the pharma partner’s pre-filled heparin syringes, saying the partner is the #2 player in the heparin space.
Get the full story at our sister site, Drug Delivery Business News.
The post Biocorp inks safety syringe deal with pharma player appeared first on MassDevice.
from MassDevice http://ift.tt/2kaVhPN
Cap comentari:
Publica un comentari a l'entrada